Diabetes Smartphone Alerts May Be Impacted by Hardware, Software Updates: FDA Warns

Disabled diabetes app alerts could lead to serious harm, including dangerous blood sugar levels, diabetic ketoacidosis injuries and death.

Federal regulators are warning that cellphone updates may disable diabetes monitoring software, leaving users potentially unaware of dangerous blood glucose levels.

Diabetes apps enable users to customize their alerts, allowing them to choose the types of notifications they receive about their condition, the frequency of these alerts, and the delivery method, whether through sounds, vibrations or text messages.

However, according to a U.S. Food and Drug Administration (FDA) safety alert published on February 5, after smartphone users download and install new cell phone updates, diabetes devices and apps may not work properly or alert the user of critical blood sugar problems.

Officials are warning this may lead to serious and potentially life threatening health conditions like hypoglycemia (low blood sugar), hyperglycemia (high blood sugar) and diabetic ketoacidosis (lack of insulin in the blood).

Do You Know About...

Childhood Diabetes Lawsuits Against Junk Food Industry

Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods.

Learn More

The FDA outlines that devices and apps that could be impacted by these updates include continuous glucose monitors (CGMs), insulin pumps, automated insulin dosing systems and other diabetic devices. Many of these diabetes monitoring devices work with smartphones and health apps to monitor a person’s blood sugar levels. When operating correctly, the devices send data to smartphones that alert the user via push notification, sound, vibration or text.

Federal regulators are now cautioning that improperly configured smartphones may cause users to miss critical diabetes safety alerts. For instance, recent updates to iPhone Operating Systems (iOS) could introduce features that are incompatible with older software used by diabetic monitors, resulting in missed notifications.

The FDA has reported multiple incidents where users of continuous glucose monitors and other diabetic devices failed to receive smartphone alerts. The agency warns that delays in receiving critical alerts can lead to severe consequences, such as dangerously low or high blood sugar levels, shock, ketoacidosis requiring urgent treatment, or even death.

Smartphone Update Recommendations

According to the agency, patients should regularly check their smartphone device alert settings, especially after phone software and hardware updates. They should pay special attention to app notification permissions, including “Do not disturb,” Focus mode” and “Deep sleep” modes, which can cause alerts not to come through.

Users should also be aware after connecting new hardware, like wireless earbuds or car audio, that can change settings and default volume levels. In addition, some operating system updates may not be supported by the diabetic device manufacturer, the agency warned.

The FDA offered these recommendations for patients:

  • Follow the instructions by the manufacturers when installing, setting up, or updating mobile medical apps on your smartphone.
  • Turn off automatic iOS updates and do not update the OS until you check the diabetes device manufacturer’s website to verify the apps you use are compatible with the OS version.
  • Check that the alerts are configured as expected at least once a month. Ensure the volume, vibration, notifications and other settings work as expected.
  • If alerts aren’t functioning as they should be, contact customer support for the medical device.

App developers may also suggest disabling “Low Power Mode,” “Adaptable Battery” and “Assistive Access.” Users may also need to enable Bluetooth and location access to the medical apps.

Any problems with diabetic devices or with the functionality of the devices and smartphone apps should be reported to the FDA’s MedWatch Adverse Event Reporting Program.

0 Comments

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page*
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process
Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (Posted yesterday)

Plaintiffs involved in Suboxone dental lawsuits indicate the bellwether selection process may be delayed due to the defendants' approach to the discovery process, which they say will cause significant delays in the litigation.